Role for Putative Hepatocellular Carcinoma Stem Cell Subpopulations in Biological Response to Incomplete Thermal Ablation: In Vitro and In Vivo Pilot Study

CardioVascular and Interventional Radiology

Volumn 37, Issue 5, 2014, Pages 1343-1351

  Thompson, Scott M ^a   Callstrom, Matthew R ^b   Butters, Kim A ^b   Sutor, Shari L ^b   Knudsen, Bruce ^b   Grande, Joseph P ^b   Roberts, Lewis R ^b   Woodrum, David A ^b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cancer stem cell; CD44; Hepatocellular carcinoma; Thermal ablation

Indexed keywords

TUMOR MARKER;

ANIMAL; CARCINOMA, HEPATOCELLULAR; DISEASE MODEL; FLOW CYTOMETRY; HEAT; IN VITRO STUDY; LIVER NEOPLASMS, EXPERIMENTAL; LOW LEVEL LASER THERAPY; METABOLISM; PILOT STUDY; PROCEDURES; RAT; STEM CELL; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HOT TEMPERATURE; IN VITRO TECHNIQUES; LASER THERAPY; LIVER NEOPLASMS, EXPERIMENTAL; PILOT PROJECTS; RATS; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892586945     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0828-3     Document Type: Article

References (48)

1. Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355:1253–1261
2. Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197(4302):461–463
3. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105–111
4. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8:755–768
5. Magee JA, Piskounova E, Morrison SJ (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21:283–296
6. Brabletz T (2012) EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 22:699–701
7. Park CY, Tseng D, Weissman IL (2009) Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol Ther 17:219–230
8. Rosen JM, Jordan CT (2009) The increasing complexity of the cancer stem cell paradigm. Science 324(5935):1670–1673
9. Tong CM, Ma S, Guan XY (2011) Biology of hepatic cancer stem cells. J Gastroenterol Hepatol 26:1229–1237
10. Haraguchi N, Ishii H, Mimori K et al (2010) CD13 is a therapeutic target in human liver cancer stem cells. J Clin Investig 120:3326–3339
11. Henry JC, Park JK, Jiang J et al (2010) miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 403:120–125
12. + cancer stem cells in human liver cancer. Cancer Cell 13:153–166
13. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27:1749–1758
14. Ma S, Chan KW, Lee TK et al (2008) Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6:1146–1153
15. Yamashita T, Forgues M, Wang W et al (2008) EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68:1451–1461
16. Terris B, Cavard C, Perret C (2010) EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. J Hepatol 52:280–281
17. Yoon SK (2012) The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma. Gut Liver 6:29–40
18. Ji J, Wang XW (2012) Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol 39:461–472
19. Rountree CB, Mishra L, Willenbring H (2012) Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology 55:298–306
20. Colombo F, Baldan F, Mazzucchelli S et al (2011) Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma. PLoS One 6:e21369
21. Marquardt JU, Raggi C, Andersen JB et al (2011) Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways. Hepatology 54:1031–1042
22. Song K, Wu J, Jiang C (2013) Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells [review]. Oncol Rep 29:3–12
23. Chen X, Lingala S, Khoobyari S et al (2011) Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J Hepatol 55:838–845
24. Lee TK, Castilho A, Ma S, Ng IO (2009) Liver cancer stem cells: implications for a new therapeutic target. Liver Int 29:955–965
25. Martelli AM, Evangelisti C, Follo MY et al (2011) Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells. Curr Med Chem 18:2715–2726
26. Dubrovska A, Kim S, Salamone RJ et al (2009) The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106:268–273
27. Sunayama J, Matsuda K, Sato A et al (2010) Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells 28:1930–1939
28. Xu Q, Simpson SE, Scialla TJ et al (2003) Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102:972–980
29. Xu Q, Thompson JE, Carroll M (2005) mTOR regulates cell survival after etoposide treatment in primary AML cells. Blood 106:4261–4268
30. Hsu HS, Lin JH, Huang WC et al (2011) Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer 117:1516–1528
31. Prinsloo E, Setati MM, Longshaw VM, Blatch GL (2009) Chaperoning stem cells: a role for heat shock proteins in the modulation of stem cell self-renewal and differentiation? Bioessays 31:370–377
32. + cells with cancer stem cell characteristics. Breast Cancer Res 10:R10
33. Lencioni R, Crocetti L (2012) Local-regional treatment of hepatocellular carcinoma. Radiology 262:43–58
34. Tiong L, Maddern GJ (2011) Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 98:1210–1224
35. Wang JH, Wang CC, Hung CH et al (2012) Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 56:412–418
36. Cho YK, Kim JK, Kim MY et al (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453–459
37. Yin XY, Xie XY, Lu MD et al (2009) Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 115:1914–1923
38. Kao WY, Chiou YY, Hung HH et al (2011) Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase–platelet ratio index. Eur J Gastroenterol Hepatol 23:528–536
39. Ng KK, Poon RT, Lo CM et al (2008) Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 12:183–191
40. Liu Y, Zheng Y, Li S et al (2013) Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol 68:21–26
41. Thompson SM, Callstrom MR, Knudsen B et al (2012) Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations. J Vasc Interv Radiol 23:385–395
42. Thompson SM, Callstrom MR, Knudsen B et al (2013) AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry. Cardiovasc Intervent Radiol 36:198–203
43. Yamashita T, Honda M, Nio K et al (2010) Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-fluorouracil by inducing hepatocytic differentiation. Cancer Res 70:4687–4697
44. Wang XQ, Ongkeko WM, Chen L et al (2010) Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology 52:528–539
45. Cheung ST, Cheung PF, Cheng CK et al (2011) Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology 140:344–355
46. Lingala S, Cui YY, Chen X et al (2010) Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol 89:27–35
47. Hermansen SK, Christensen KG, Jensen SS, Kristensen BW (2011) Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma. J Histochem Cytochem 59:391–407
48. Mather JP (2012) In vitro models. Stem Cells 30:95–99